Annual EBITDA
$4.31 B
+$5.49 B+465.89%
March 31, 2024
Summary
- As of March 14, 2025, ROIV annual EBITDA is $4.31 billion, with the most recent change of +$5.49 billion (+465.89%) on March 31, 2024.
- During the last 3 years, ROIV annual EBITDA has risen by +$5.21 billion (+581.19%).
- ROIV annual EBITDA is now at all-time high.
Performance
ROIV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$271.46 M
+$65.41 M+19.42%
December 31, 2024
Summary
- As of March 14, 2025, ROIV quarterly EBITDA is -$271.46 million, with the most recent change of +$65.41 million (+19.42%) on December 31, 2024.
- Over the past year, ROIV quarterly EBITDA has increased by +$65.41 million (+19.42%).
- ROIV quarterly EBITDA is now -105.53% below its all-time high of $4.91 billion, reached on March 31, 2024.
Performance
ROIV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$4.39 B
-$55.89 M-1.26%
December 31, 2024
Summary
- As of March 14, 2025, ROIV TTM EBITDA is $4.39 billion, with the most recent change of -$55.89 million (-1.26%) on December 31, 2024.
- Over the past year, ROIV TTM EBITDA has dropped by -$55.89 million (-1.26%).
- ROIV TTM EBITDA is now -4.32% below its all-time high of $4.59 billion, reached on June 30, 2024.
Performance
ROIV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ROIV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +465.9% | +19.4% | -1.3% |
| 3 y3 years | +581.2% | +19.4% | -1.3% |
| 5 y5 years | +581.2% | +19.4% | -1.3% |
ROIV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +465.9% | -105.5% | +26.3% | -4.3% | +437.4% |
| 5 y | 5-year | at high | +465.9% | -105.5% | +26.3% | -4.3% | +437.4% |
| alltime | all time | at high | +465.9% | -105.5% | +26.3% | -4.3% | +437.4% |
Roivant Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$271.46 M(-19.4%) | $4.39 B(-1.3%) |
| Sep 2024 | - | -$336.87 M(-481.0%) | $4.45 B(-3.1%) |
| Jun 2024 | - | $88.43 M(-98.2%) | $4.59 B(+9.5%) |
| Mar 2024 | $4.31 B(-465.9%) | $4.91 B(-2378.4%) | $4.19 B(-573.0%) |
| Dec 2023 | - | -$215.57 M(+10.9%) | -$885.95 M(-14.7%) |
| Sep 2023 | - | -$194.35 M(-37.6%) | -$1.04 B(-9.3%) |
| Jun 2023 | - | -$311.34 M(+89.0%) | -$1.14 B(-2.8%) |
| Mar 2023 | -$1.18 B | -$164.69 M(-55.3%) | -$1.18 B(-9.5%) |
| Dec 2022 | - | -$368.48 M(+22.7%) | -$1.30 B(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$300.35 M(-12.8%) | -$1.24 B(+6.6%) |
| Jun 2022 | - | -$344.50 M(+19.5%) | -$1.16 B(+26.9%) |
| Mar 2022 | -$910.77 M(+1.7%) | -$288.30 M(-4.9%) | -$913.63 M(-7.8%) |
| Dec 2021 | - | -$303.18 M(+35.5%) | -$991.01 M(+4.7%) |
| Sep 2021 | - | -$223.69 M(+127.2%) | -$946.90 M(+7.6%) |
| Jun 2021 | - | -$98.47 M(-73.1%) | -$879.76 M(-1.8%) |
| Mar 2021 | -$895.74 M | -$365.67 M(+41.1%) | -$895.74 M(+69.0%) |
| Dec 2020 | - | -$259.07 M(+65.5%) | -$530.06 M(+95.6%) |
| Sep 2020 | - | -$156.54 M(+36.8%) | -$270.99 M(+136.8%) |
| Jun 2020 | - | -$114.45 M | -$114.45 M |
FAQ
- What is Roivant Sciences annual EBITDA?
- What is the all time high annual EBITDA for Roivant Sciences?
- What is Roivant Sciences annual EBITDA year-on-year change?
- What is Roivant Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Roivant Sciences?
- What is Roivant Sciences quarterly EBITDA year-on-year change?
- What is Roivant Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for Roivant Sciences?
- What is Roivant Sciences TTM EBITDA year-on-year change?
What is Roivant Sciences annual EBITDA?
The current annual EBITDA of ROIV is $4.31 B
What is the all time high annual EBITDA for Roivant Sciences?
Roivant Sciences all-time high annual EBITDA is $4.31 B
What is Roivant Sciences annual EBITDA year-on-year change?
Over the past year, ROIV annual EBITDA has changed by +$5.49 B (+465.89%)
What is Roivant Sciences quarterly EBITDA?
The current quarterly EBITDA of ROIV is -$271.46 M
What is the all time high quarterly EBITDA for Roivant Sciences?
Roivant Sciences all-time high quarterly EBITDA is $4.91 B
What is Roivant Sciences quarterly EBITDA year-on-year change?
Over the past year, ROIV quarterly EBITDA has changed by +$65.41 M (+19.42%)
What is Roivant Sciences TTM EBITDA?
The current TTM EBITDA of ROIV is $4.39 B
What is the all time high TTM EBITDA for Roivant Sciences?
Roivant Sciences all-time high TTM EBITDA is $4.59 B
What is Roivant Sciences TTM EBITDA year-on-year change?
Over the past year, ROIV TTM EBITDA has changed by -$55.89 M (-1.26%)